Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]Ga-FAPI PET/CT for Melanoma Response Evaluation
NCT07215182Phase 2Recruiting
- Start
- Aug 2025
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial. Primary endpoint: Changes in FAPI-uptake in malignant lesions at 3 months. Started Aug 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07215182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07215182.